Plain-English translation of NCT07685860 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Depression research guide →This trial is testing a new brain imaging technique using a radioactive tracer called 18F-AIPF-1026 combined with PET/CT scans. Researchers want to see if this imaging method can help identify and measure brain changes related to depression, anxiety, and heart problems. The goal is to develop a better tool for diagnosing and monitoring these conditions.
Current methods for diagnosing depression and anxiety don't always clearly show what's happening in the brain. This trial exists to see if this new imaging approach can provide clearer pictures of the brain changes involved in these conditions, potentially leading to better diagnosis and treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will receive a single injection of a radioactive tracer through your vein, and then lie still inside a PET/CT scanner (or possibly an MRI machine) for imaging. The scan itself typically takes 30 minutes to an hour. You may be asked to return for follow-up imaging if researchers need to check your condition again over time.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
China
Sponsor
Tianjin Medical University
Collaborators
Tianjin Medical University General Hospital
Enrollment target
~200 participants
Started
June 2026
Primary completion
July 2029
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ying Wang, MD
Tianjin Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.